Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Pancreatic PHIP-mediated control of í-cell survival and inflammatory responses
FY 2016-17
Summary
DNA is tightly wrapped around proteins to form a compact structure called chromatin. Chemical groups added to chromatin can turn the expression of nearby genes on or off, and several proteins read, add or remove these epigenetic marks. Increasing evidence suggests that disruptions in chromatin modifications or the corresponding proteins can influence autoimmune diseases. Type 1 diabetes (T1D) is a chronic autoimmune disease where the selective loss of insulin-producing pancreatic ?-cells is partly driven by immune responses and defects in ?-cell biology. A set of chromatin readers called bromodomain proteins have shown to regulate inflammatory and metabolic genes through multiple downstream mechanisms that might significantly contribute to T1D outcomes. This proposal introduces a novel downstream bromodomain protein of the insulin receptor signalling pathway discovered by Dr. Rozakis' group, called PHIP. Previous data and current undergoing work in our lab renders us to believe that 1) PHIP is involved in the induction of gene expression programs that contribute to ?-cell growth/survival and 2) PHIP plays a protective role in ?-cells by controlling the expression of genes involved in inflammatory responses. The main goal of this proposal is to gain some mechanistic insight and directly assess whether PHIP is essential to perform these functions, by using two novel genetically engineered mice with 1) selective loss of PHIP and 2) selective overexpression of PHIP in ?-cells. We intend to perform growth/survival assays, PHIP transcriptome and proteome analysis, and epigenetic assays in mouse islets in an effort to understand PHIP-based mechanisms that promote ?-cell homeostasis and glucoregulatory control in type 1 diabetes.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367155
Name
Jain Srishti
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Pancreatic PHIP-mediated control of í-cell survival and inflammatory responses
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bromodomains; Cre/Lox Mouse Models; Epigenetics; Growth/Survival Pathways; Islet Inflammation; Phip; Proteomics; Transcriptomics; Type 1 Diabetes; Í-Cells
Abstract
DNA is tightly wrapped around proteins to form a compact structure called chromatin. Chemical groups added to chromatin can turn the expression of nearby genes on or off, and several proteins read, add or remove these epigenetic marks. Increasing evidence suggests that disruptions in chromatin modifications or the corresponding proteins can influence autoimmune diseases. Type 1 diabetes (T1D) is a chronic autoimmune disease where the selective loss of insulin-producing pancreatic ?-cells is partly driven by immune responses and defects in ?-cell biology. A set of chromatin readers called bromodomain proteins have shown to regulate inflammatory and metabolic genes through multiple downstream mechanisms that might significantly contribute to T1D outcomes. This proposal introduces a novel downstream bromodomain protein of the insulin receptor signalling pathway discovered by Dr. Rozakis' group, called PHIP. Previous data and current undergoing work in our lab renders us to believe that 1) PHIP is involved in the induction of gene expression programs that contribute to ?-cell growth/survival and 2) PHIP plays a protective role in ?-cells by controlling the expression of genes involved in inflammatory responses. The main goal of this proposal is to gain some mechanistic insight and directly assess whether PHIP is essential to perform these functions, by using two novel genetically engineered mice with 1) selective loss of PHIP and 2) selective overexpression of PHIP in ?-cells. We intend to perform growth/survival assays, PHIP transcriptome and proteome analysis, and epigenetic assays in mouse islets in an effort to understand PHIP-based mechanisms that promote ?-cell homeostasis and glucoregulatory control in type 1 diabetes.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jain, Srishti
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~